Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi) closing bell: the sector bounces off Tuesday’s low

December 6, 2018 5:58pm

After every big sell-off, the oversold end up overbought as bottoms are in demand

How many times, can I be right – more than most!

Out and about: Global Blood therapeutics (GBT +$1.22 or +2.68% to $46.67) proposes offering to sell $150 M in shares; Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. MiMedx (MDXG -$1.75 or -59.32%) get hammered on news of more unreliable financial statements causing a 25% reduction in force (RIF) of employees as it promotes executives and auditor Ernst&Young resigns.

Pre-open indications: 10 HITs and 4 MISS

Investors should be reading about the facts and figures in evidence – be a subscriber!

Members only. Please login.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

2 hours 43 min ago
RegMed Investors (RMi) Closing Bell: this week’s trend is an admission that the sector is without pricing sustainability suppressing a value directional

11 hours 44 min ago
RegMed Investors’ (RMi) pre-open: the down draft doesn’t seem to be over

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.